Private Wealth Partners, LLC Biogen Inc. Transaction History

Private Wealth Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 02, 2019	SELL	$216.71 - $338.96 $146,279 - $228,798	-675 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$293.51 - $383.83 $198,119 - $259,085	675 New	675 $238,000
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $206,016 - $245,528	-800 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $52,026 - $73,582	-200 Reduced 20.0%	800 $219,000
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $281,150 - $329,690	1,000	1,000 $313,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Private Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Wealth Partners, LLC with notifications on news.